Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

• Status: Completed
• Trial end date: 2005-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Dexmethylphenidate Hydrochloride

Criteria

Inclusion Criteria:

• DSM-IV diagnosis of ADHD

• Males and females aged 6-12

Exclusion Criteria:

• Inability to understand or follow instructions

• Is pregnant

• Diagnosis of tic disorder

• History of seizure disorder